47
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Mycoses associated with AIDS in the Third World

, , , , &
Pages 269-279 | Published online: 01 Apr 2010

References

  • Franco M. Host-parasite relationship in paracoccidioidomyco-sis. J Med Vet Mycol 1986; 25: 5–18.
  • Sugar AM, Restrepo A, Stevens D. Paracoccidioidomycosis in the immunosupressed host: report of a case and review of the literature. Am Rev Respir Dis 1988; 129: 340–342.
  • Marques SA, Shikanay-Yasuda MA. Paracoccidioidomycosis associated with immunosuppression, AIDS and cancer. In: Franco M, Lacaz CS, Restrepo-Moreno A, Del Negro G, eds. Paracoccidioidomycosis, 1st edn. Boca Raton, FL: CRC Press, 1994: 393–405.
  • Goldani LZ, Sugar AM. Paracoccidioidomycosis and AIDS: an overview. ain Infect Dis 1995; 12: 1275–1281.
  • Fauci AS. The AIDS epidemic—considerations for the 21st Century. New Engl J Med 1999; 341: 1046–1050.
  • Anonymous. Distribuicao dos casos de AIDS no Brasil 1980-1999. Boletim Epidemiologico AIDS—Ministerio da Saude do Brasil 1999; 12: 25–53.
  • Minamoto GY, Rosemberg AS. Fungal infection in patients with the acquired immunodeficiency syndrome. Med ain North Am 1997; 81: 381–389.
  • Goldani LZ, Martinez CAM, Landell AAM, Coutinho V. Paracoccidioidomycosis in a patient with the acquired im-munodeficiency syndrome. Mycopathologia 1989; 105: 71–74.
  • Bakos L, Kronfeld M, Hampe S, Castro I, Zampese M. Disseminated paracoccidioidomycosis with skin lesion in a patient with acquired immunodeficiency syndrome. J Am Acad Dermatol 1989; 20: 854–855.
  • Pedro RJ, Aoki FJ, Bocatto RSBS, et al. Paracoccidioidomi-cose e infeccao pelo virus da imunodeficiencia humana. Rev Inst Med Trop Sao Paulo 1989; 31: 119–125.
  • Marques SA, Contemo LO, Sgarbi LP, et al. Paracoccid-ioidomycosis associated with acquired immunodeficiency syn-drome. Report of seven cases. Rev Inst Med Trop Sao Paulo 1995; 37: 261–265.
  • Lima MA, Silva-Vergara ML, Demachki S, Santos JAM. Paracoccidioidomicosis em paciente com a infeccao pelo virus da imunodeficiencia humana. Relato de necropsia. Rev Soc Bras Med Trop 1995; 28: 279–284.
  • Santos FO, Silva N, Espinheira L, et al. Desenvolvimento de resistencia ao cotrimoxazol durante o tratamento de paracoc-cidioidomicose em paciente com SIDA. Rev Soc Br Med Trop 1995; 28 (Suppl. 1): 103.
  • Segurado AAC, Artoga MPG, Santos SS, et al. Paracoccid-ioidomicose como manifestacao oportunista na evolucao da imunodeficiencia adquirida, relato de dois casos. Rev Soc Br Med Trop 1995; 28 (Suppl. 1): 232.
  • Cinerman S, Bacha HA, Ladeira MCT, Silveira OS, Colombo AL. Paracoccidioidomycosis in a boy infected with HIV. Mycoses 1997; 40: 343–344.
  • Nogueira SA, Caiuby J, Vasconcelos V, et al. Paracoccid-ioidomycosis and tuberculosis in AIDS patients: report of two cases in Brazil. Int J Infect Dis 1998; 2: 168–172.
  • Santos JWA, Costa JM, Cechella M, Michel GT, Figueiredo WC, Londero AT. An unusual presentation of paracoccid-ioidomycosis in an AIDS patient: a case report. Mycopatholo-gia 1998; 142: 139–142.
  • Nouer S, Ahneida YC, Aoki FH, Branchini ML, Papaior-danou PMO. Paracoccidioidomicose associada a AIDS. Re-lato de 10 casos. Program and Abstracts of the Congresso Brasileiro de Micologia. Rio de Janeiro: Brasil, 1998; Abstract MO.
  • Oliveira SR, Mendes RP. A case report of paracoccidioidomy-cosis (PBM) in an AIDS patient. Program and abstracts of the II Congresso Brasileiro de Micologia, Rio de Janeiro. Rio de Janeiro: Sociedade Brasileira de Micologia, 1998; Abstract A163.
  • Albuquerque Neto LL, Eulalio KD, Dantas LFS, Aita GA, Araujo RM, Silva DM. Paracoccidioidomicose simulando Mal de Pott em portador de SIDA. Rev Soc Br Med Trop 1999; 32 (Suppl. 1): 485.
  • Maffei F, Ibrahim KI, Litvoc MN, et al. Paracoccidioidomi-cose pulmonar e adrenal em paciente infectado pelo virus HIV. Relato de caso. Rev Soc Med Trop 1999; 32 (Suppl. 1): 347.
  • Lacaz CS, Porto E, Martins JE. Micologia Medica, 8th edn. Sao Paulo: Sarvier FIlitora, 1991: 248–297.
  • Haddad DJ, Pires MFC, Petry TC, et al. Paracoccidioides brasiliensis (Lutz, 1908) isolado por meio de hemocultura em um paciente portador de Sindrome de imunodeficiencia Adquirida. Rev Inst Med Trop Sao Paulo 1992; 34: 565–567.
  • Tobon AM, Orozco B, Estrada S, et al. Paracoccidioidomyco-sis and AIDS: report of the first two Colombian cases. Rev Inst Med Trop Sao Paulo 1998; 40: 377–381.
  • Heussel CP, Kauczor HU, Heussel G, Thelen M, Jahn B. Multiple renal aspergillus abscesses in an AIDS patient: Con-trast-enhanced helical CT and MRI findings. Eur Ew Radiol 1999; 9: 616–619.
  • Richardson M, Warnock D. Fungal Infection Diagnosis and Management, 2nd edn. Oxford: Blackwell Science, 1997.
  • Denning D. State-of-the-art clinical article. Invasive asper-gillosis. Clin Infect Dis 1998; 26: 781–805.
  • Khoo S, Denning D. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1994; 19 (Suppl. 1): S41–48.
  • Negroni R. Micosis asociadas con el SIDA. En SIDA y enfermedades asociadas. Buenos Aires: Lopez Libreros Edi-tores, 1997: 233–238.
  • Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Micro-biol Rev Apr 1999; 30: 310–350.
  • Maertens J, Verhagen J, Demuynck H, et al. Autopsy-con-trolled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive aspergillosis. J Gun Microbiol 1999; 37: 3223–3228.
  • Viviani MA, Tortorano AM. Penicillium marneffei. In: Nell° L, Hay RJ, eds. Topley &Wilson's Microbiology and Microbial Infections, 9th edn. London: Arnold, 1998: 409–419.
  • Sirisanthana T, Supparatpinyo K. Epidemiology and manage-ment of penicilliosis in human immunodeficiency virus-in-fected patients. Int .1 Infect Dis 1998; 3: 48–53.
  • Chariyalertsak S, Sirisanthana T, Supparatpinyo K, Praparat-tanapan J, Nelson KE. Case-control study of risk factors for Penicillium marneffei infection in human immunodeficiency virus-infected patients in Northern Thailand. Clin Infect Dis 1997; 24: 1080–1086.
  • Hamilton AJ, Jeavons L, Youngchim S, Vanittanakom N. Recognition of fibronectin by Penicillium marneffei conidia via a sialic acid-dependent process and its relationship to the interaction between conidia and laminin. Infect Immun 1999; 67: 5200–5205.
  • Kudeken N, Kawakami K, Saito A. Cytokine-induceid fungici-dal activity of human polymorphonuclear leukocytes against Penicillium marneffei. FEMS Immunol Med Microbiol 1999; 26: 115–124.
  • Drouhet E. Penicilliosis due to Penicillium marneffei. A new emerging systemic mycosis in AIDS patients travelling or living in Southeast Asia. Review of 44 cases reported in HIV infected patients during the last 5 years compared to 44 cases of non AIDS patients reported over 20 years. J Mycol Med 1993; 4: 195–224.
  • Cooper CR. From bamboo rats to humans: the odyssey of Penicillium marneffei. ASM News 1998; 64: 390–397.
  • Kaufman L, Standard PG, Anderson SA, Jalbert M, Swisher BL. Development of specific fluorescent-antibody test for tis-sue form of Penicillium marneffei. J Gun Microbiol 1995; 33: 2136–2138.
  • Vanittanakom N, Merz WG, Sittisombut N. Specific identifi-cation of Penicillium marneffei by a polymerase chain reaction/ hybridization technique. Med Mycol 1998; 36: 169–175.
  • Sekhon AS, Li JSK, Garg AK. Penicilliosis marneffei: serolog-ical and exoantigen studies. Mycopathology 1982; 77: 51–57.
  • Van Cutsem J, Meulemans L, Van Gerven F, Stynen D. Detection of circulating galactomannan by Pastorex Asper-gillus in experimental invasive aspergillosis. Mycoses 1990; 33: 61–69.
  • Rimek D, Zimmermann T, Hartmann M, Prariyachatigul C, Kappe R. Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany. Mycoses 1999; 42 (Suppl. 2): 25–28.
  • Kaufman L, Standard PG, Jalbert M. Diagnostic antigenemia tests for penicilliosis marneffei. J Clin Microbiol 1996; 34: 2503–2505.
  • Cao L, Chan KM, Chen D, et al. Detection of cell wall mannoprotein Mplp in culture supernatants of Penicillium marneffei and in sera of penicilliosis patients. J Gun Microbiol 1999; 37: 981–986.
  • Desakorn V, Smith MD, Walsh AL, et al. Diagnosis of Penicillium marneffei infection by quantitation of urinary anti-gen by using an enzyme immunoassay. J Gun Microbiol 1999; 37: 117–121.
  • Supparatpinyo K, Perriens J, Nelson KE, Sirisanthana T. A controlled trial of itraconazole to prevent relapse of Penicil- huminfection in patients infected with the humanimmunodeficiency virus. New Engl J Med 1998; 339: 1739–1743.
  • Sirisanthana T, Supparatpinyo K, Perriens J, Nelson KE. Amphotericin B and itraconazole for treatment of dissemi-nated Penicillium marneffei infection in human immunodefi-ciency virus-infected patients. Clin Infect Dis 1998; 26: 1107–1110.
  • Aly R, Berger T. Common superficial fungal infections in patients with AIDS. Clin Infect Dis 1996; 22 (Suppl. 2): S128–S132.
  • Elmets CA. Management of common superficial fungal infec-tions in patients with AIDS. J Am Acad Dermatol 1994; 31: S60–S63.
  • Fernandez Bussi RA. Micosis con manifestaciones cutaneas en pacientes con SIDA. Program and Abstracts of the VII Con-gresso Argentino de Micologia, Rosario, Argentina. Buenos Aires: Sociedade Argentina de Micologia, 1995: 16.
  • Lobrone JP, Lazare K, Medard FT, Zekeng L. Clinical and biological study of superficial mycoses in AIDS patients in Yaounde. Program and Abstracts of the 12th International Conference on AIDS, Geneva. Geneva: World Health Organi-zation, 1998: Abstract 31218.
  • Weismann K, Knudsen EA, Pedersen C. White nails in AIDS/ ARC due to Trichophyton rubrum infection. Clin Exp Derma-tol 1988; 13: 24–25.
  • Dompmartin D, Dompmartin A, Deluol AM, Grosshans E, Couland JP. Onychomycosis in AIDS: Clinical and laboratory findings in 62 patients. Int J Dermatol 1990; 29: 337–339.
  • Gregory N. Special patient populations: onychomycosis in the HIV positive patient. J Am Acad Dermatol 1996; 35: S13–S16.
  • Cuetara MS, Die Palacio A, Noriega AR, Picazo JJ, Costa R, Rubio R. The value of superficial yeast cultures in HIV patients with mycoses. In: Program and Abstracts of the Inter-national Conference of Intersciences. San Francisco: Antimi-crobial Agents and Chemotherapy, 1995: Abstract 213.
  • Pereiro M, Losada A, Toribio J. Adherence of Candida albi-cans strains isolated from AIDS patients. Comparison with pathogenic yeasts isolated from patients without HIV infec-tion. Br J Dermatol 1997; 137: 76–80.
  • Lopez-Dupla M, Mora-Sanz P, Pintado-Garcia V, et al. Clin-ical, endoscopic, immunologic and therapeutic aspects of oropharyngeal and esophageal candidiasis in HIV infected patients: a survey of 114 cases. An J Gastroenterol 1992; 87: 1771-1776.
  • Martinez-Machin G, Perurena-Lancha N, Nufiez-Carbajal J, Fernandez-Andreu CN, Baudera-Tirado F. Isolation, identifi-cation and typing of yeast from HIV positive patients with oral candidiasis. Rev Cabana Med Trop 1997; 49: 174–180.
  • Kwon-Chung KJ, Bennett JE. Histoplasmosis. In: Kwon-Chung KJ, Bennett JE, eds. Medical Mycology. Philadelphia: Lea & Febiger, 1992: 464–513.
  • Negroni R. Classical histoplasmosis. In: De Vroey CH, Gatti F, eds. Human Mycoses in Tropical Countries. Health Cooper-ation Papers, Vol. 8. Bologna: Associazione Italiana Amici de R. Follearau, 1990: 203–210.
  • Wu-Hsieh Y, Howard H. Histoplasmosis. In: Murphy J, Friedman H, Hbendinelli M, eds. Fungal Infections and Im-mune Responses. New York: Plenum Press, 1993: 213–250.
  • George RB, Penn RL. Histoplasmosis. In: Sarosi G, Davies S, eds. Fungal Diseases of the Lung. New York: Raven Press, 1993: 39–50.
  • Bullock WE. Histoplasma capsulatum. In: Mandell G, Douglas JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 4th edn. New York: Churchill Livingston, 1995: 2340–2353.
  • Tewari R, Wheat U, Aiello L. Agents of histoplasmosis. In: Ajello L, Hay R, eds. Topley & Wilson's Microbiology and Microbial Infections, 9th edn. London: Arnold, 1998:373–393.
  • Wheat LJ, Slama TG, Zeckel ML. Histoplasmosis in the acquired immunodeficiency syndrome. Am J Med 1985; 78: 203–210.
  • Wheat U. Histoplasmosis and Coccidioidomycosis in individ-uals with AIDS. Infect Dis Clin North Am 1994; 8: 467–482.
  • Negroni R, Robles AM, Arechavala A, Taborda A. Histoplas-mosis diseminada en pacientes con SIDA, su evoluci6n y tratamiento. Rev Argent Micologia 1991; 14: 5–12.
  • Negroni R, Iovannitti C, Arechavala A, Camovale S, Euguchi K. Preparación y estudio de un exoantigeno de la fase levadu-riforme de Histoplasma capsulaturn para reacciones serológi-cas. Rev Iberoamer Micol 1998; 15: 282–285.
  • Arechavala A, Euguchi K, Iovannitti C, Negroni R. Utilidad del enzimoinmunoensayopara el serodiagn6stico de histoplas-mosis asociada al S1DA. Rev Argent Micol 1997; 20: 24–28.
  • Wheat LJ. Histoplasma capsulatum. In: Yu V, Merigan TC, Barriere SL, eds. Antimicrobial Therapy and Vaccines. Balti-more: William & Wilkins, 1999: 1109–1113.
  • Bava Al, Negroni R. Caracteristicas epidemiol6gicas de 105 casos de criptococosis diagnosticados en la Republica Ar-gentina entre 1981-1990. Rev Inst Med Trop Siio Paulo 1992; 34: 335–340.
  • Lopez CE, Ramos LL. Hallazgos micológicos en materiales provenientes de pacientes HIV ( + ). Rev Argent Micol 1997; 20: 16–19.
  • Bava AJ, Negroni R, Arechavala A, Robles AM, Bianchi M. Cryptococcosis associated with AIDS in the Mufliz Hospital of Buenos Aires. Mycopathologia 1997; 140: 13–17.
  • Fernandez A, Parhuana A, Vasquez M, Simon P, Castro J. Meningitis criptocococica y sindrome de inmunodeficiencia adquirida en el Hospital Nacional Dos de Mayo. An Fac Med (Peru) 1996; 57: 98–102.
  • Ord6fiez N, Torrado E, Castaileda E. Criptococosis meningea de 1990 a 1995: hallazgos de laboratorio. Biomedica 1996; 16: 93–97.
  • Darzé C, Lucena R, Gomes I, Melo A. Caracteristicas clinicas laboratoriais de 104 casos de meningoencefalite criptocócica. Rev Soc Bras Med Trop 2000; 33: 21–26.
  • Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515–548.
  • Speed B, Dunt D. Clinical and host differences between infec-tions with the two varieties of Cryptococcus neoformans. Clin Infect Dis 1995; 8: 28–34.
  • Capece P, Casanova N, Raffo L, Gammella D, Bava Al. Criptococosis asociada al SIDA en el Hospital Posadas: estu-dio de 30 casos. Rev Argent Micol 1997; 20: 20–23.
  • Helou S, Robles AM, Arechavala A, Bianchi MI, Negroni R. Criptococcisis respiratoria en pacientes VIH positivos. Rev Iberoam Micol 1999; 16: 126–129.
  • Calvo B, Fischman 0, Pignatari A, Del Bianco R, Zaror R. Variants and serotypes of Cryptococcus neoformans in patients with AIDS and neurocryptococcosis. Rev Inst Med Trop Siio Paulo 1990; 32: 480–482.
  • Bava Al, Negroni R, Robles AM, et al. Caracteristicas epi-demiológicas de 71 casos de criptococosis diagnosticados en diferentes centros assistenciales de la ciudad de Buenos Aires y alrekledores durante 1991. Infect Microbiol Clin 1992; 4: 85–89.
  • Rozenbaum R, Rios-Goncalves Al, Wanke B, et al. Crypto-coccus neoformans varieties as agents of cryptococcosis in Brazil. Arq Bras Med 1992; 66: 261–263.
  • Padhye AA, Chakrabarti A, Chander J, Kaufman L. Crypto-coccus neoformans var. gattii in India. J Med Vet Mycol 1993; 31: 165–168.
  • Cavalcanti MAS. Criptococose e seu agente etiológico no Meio Norte, Estados do Piaui e Maranhao, Brasil. PhD thesis. Institut° Oswaldo Cruz, Rio de Janeiro, 1996.
  • Fernandes OFL, Costa TR, Costa MR, Soares AJ, Pereira AJSC, Silva MRR. Cryptococcus neoformans isolados de pa-cientes com AIDS. Rev Soc Bras Med Trop 2000; 33: 75–78.
  • Ferreira MS, Borges AS, Barbosa HMR, et al. Criptococose: estudo de 82 casos observados na regiao do Triangulo Mineiro. Rev Soc Bras Med Trop 2000; 33 (Suppl. 1): 456.
  • Almeida AMF. Andlise do cariótipo eletroforético de difer-entes amostras de Cryptococcus neoformans e correlacão com suscetibilidade a drogas antiffingicas. Master's dissertation. Institut° de Quanica da Universidade Estadual Paulista, Araraquara, 2000.
  • Kapend'a K, Komichelo K, Swine D, Vandepitte J. Meningitis due to Cryptococcus neoformans var. gattii in a Zairean AIDS patient. Eur J Gun Microbiol 1987; 6: 320–321.
  • Rozenbaum R, Rios-Goncalves AJ, Wanke B, Vieira W. Cryptococcus neoformans var. gattii in a Brazilian AIDS pa-tient. Mycopathologia 1990; 112: 33–34.
  • Bogaerts J, Taelman H, Batungwanayo J, Van de Perre P, Swinne D. Two cases of HIV-associated cryptococcosis due to the variety gattii in Rwanda. Trans R Soc Trop Med Hyg 1993; 87: 63–64.
  • Castefión-Olivares LR, Lopez-Martinez R, Barriga-Angulo G, Rios-Rosas C. Cryptococcus neoformans var. gattii in an AIDS patient: first observation in Mexico. J Med Vet Mycol 1997; 35: 57–59.
  • Severo LC, Oliveira FM, Londero AT. Cryptococcosis due to Cryptococcus neoformans var. gattii in Brazilian patients with AIDS. Report of three cases. Rev Iberoam Micol 1999; 16: 152–154.
  • St-German G, Noel G, Kwon-Chung KJ. Disseminated cryp-tococcosis due to Cryptococcus neoformans var. gattii in a Canadian patient with AIDS. Eur J Gun Microbiol Infect Dis 1988; 7: 587–588.
  • Clancy MN, Fleischmann J, Howard DH, Kwon-Chung KJ, Shimizu RY. Isolation of Cryptococcus neoformans gattii from a patient with AIDS in southern California. J Infect Dis 1990; 161: 809.
  • Peetermans W, Bobbaers H, Verhaegen J, Vandepitte J. Flu-conazole-resistant Cryptococcus neoformans var. gattii in an AIDS patient. Acta Clin Belg 1993; 48: 405–409.
  • Speed BR, Strwbridge L, Ellis DH. Cryptococcus neoformans var. gattii meningitis in an Australian patient with AIDS. J Med Vet Mycol 1993; 31: 395–399.
  • Abraham M, Mathews V, Ganesh A, John TJ, Mathews MS. Infection caused by Cryptococcus neoformans var. gattii serotype in an AIDS patient in India. J Med Vet Mycol 1997; 35: 283–284.
  • Montagna MT, Tortorano AM, Fiori L, Ingletti AM, Barbuti S. Cryptococcus neoformans var. gattii en Italie. Note I. Pre-mier cas autochtone de méningite a serotype B chez un sujet VIH positif. J Mycol Med 1997; 7: 90–92.
  • Marriott DJE, Speed BR, Spelman D, Shaw D, French M, Harkness JL. Cryptococcus neoformans var. gattii infection in Australian HIV-infected patients: a review of seven cases. Third International Conference on Cryptococcus and Ctypto-coccosis, September 22–26, 1996, Paris. Paris: Institut Pasteur, 1996: Abstract 3.10.
  • Lazéra MS, Pires FDA, Camillo-Coura L, et al. Natural habitat of Cryptococcus neoformans var. neoformans in decay-ing wood forming hollows in living trees. J Med Vet Mycol 1996; 34: 127–131.
  • Fromtling RA, Abruzzo GK, Ruiz A. Virulence and antifun-gal susceptibility of environmental and clinical isolates of Cryptococcus neoformans from Puerto Rico. Mycopathologia 1989; 106: 163–166.
  • Franzot SP, Hamdan JS, Currie BP, Casadevall A. Molecular epidemiology of Cryptococcus neoformans in Brazil and the United States: evidence for both local genetic differences and a global clonal population structure. J Gun Microbiol 1997; 35: 2243–2251.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.